In neuroblastoma, ALK has been shown to be involved in cell proliferation, migration and invasion and ALK mutations have been reported in around 50% of hereditary and 8-10% of sporadic cases, occurring across all risk groups and more frequently at relapse [4–9]. This evidence concerns the gene ALK and neuroblastoma.